Entry Detail



General Information

Database ID:exR0093064
RNA Name:hsa-miR-1294
RNA Type:miRNA
Chromosome:chr5
Starnd:+
Coordinate:
Start Site(bp):154347153End Site(bp):154347174
External Links:hsa-miR-1294



Disease Information

Disease Name:Benign Ovarian Disease
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D010049
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Ovarian Diseases//Disease, Ovarian//Diseases, Ovarian//Ovarian Disease



Expression Detail

GEO ID:GSE106817
Description:Integrated extracellular microRNA profiling for ovarian cancer screening
Experimental Design:Cancer vs Control
Case Disease Type:Benign Ovarian Disease
Case Disease SubType:NA
Case Sample:Benign Ovarian Disease
Control Sample:Non-Cancer
Number of Case:29
Number of Control:2759
Number of Samples:2788





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
CYB5R3
chr22
42617840
42649392
-
STK40
chr1
36339624
36385896
-
EIF4A1
chr17
7572706
7579006
+
TRAPPC10
chr21
44012309
44106552
+
ABCA1
chr9
104781006
104928155
-
POGK
chr1
166839447
166856344
+
FGFR1
chr8
38400215
38468834
-
KMT2A
chr11
118436490
118526832
+
RAB8A
chr19
16111889
16134234
+
TEX261
chr2
70985942
70994873
-
ANKRD49
chr11
94493979
94499578
+
PGRMC1
chrX
119236245
119244466
+
PTMS
chr12
6765516
6770952
+
CRY2
chr11
45847118
45883248
+
PTP4A1
chr6
63521746
63583436
+
APLP2
chr11
130068147
130144811
+
CDKN1B
chr12
12715058
12722369
+
UBE2G2
chr21
44768580
44801826
-
PDPR
chr16
70113626
70162537
+
AKT2
chr19
40230317
40285536
-
RNF157
chr17
76142465
76240493
-
ZHX3
chr20
41178448
41317672
-
ARHGAP28
chr18
6729718
6915716
+
PRRC2B
chr9
131373636
131500197
+
FYCO1
chr3
45917899
45995824
-
ZNF512B
chr20
63956704
63969930
-
SMAD7
chr18
48919853
48952052
-
PDE4DIP
chr1
148808181
149048286
+
TAGLN2
chr1
159918107
159925732
-
NACC1
chr19
13116862
13141147
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000247
chr10
74474868
74475660
+
hsa_circ_0000798
chr17
65941524
65944422
+
hsa_circ_0000246
chr10
74468040
74475660
+
hsa_circ_0001085
chr2
191765289
191789319
+
hsa_circ_0000744
chr17
15968183
15971435
-
hsa_circ_0000799
chr17
65941524
65972074
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC007161.3
chr7
7640752
8004053
+
AC021078.1
chr5
149494314
149504670
-
AC022150.4
chr19
52650437
52653284
-
AL022311.1
chr22
37876148
37895563
+
H19
chr11
1995176
2001470
-
LINC00265
chr7
39733430
39793092
+
NEAT1
chr11
65422774
65445540
+
TUG1
chr22
30969245
30979395
+
Display:



Experiment Detail

GEO ID:GSE106817
Sample Source:Blood
Source Fraction:Serum
Platform:GPL21263
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2535
Sample treatment protocol:NA
RNA Extract protocol:Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.).
RNA library preparation protocol:miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.



Reference

PMID:30333487
Title:Integrated extracellular microRNA profiling for ovarian cancer screening
Author:Yokoi A, Matsuzaki J, Yamamoto Y, Yoneoka Y, Takahashi K, Shimizu H, Uehara T, Ishikawa M, Ikeda SI, Sonoda T, Kawauchi J, Takizawa S, Aoki Y, Niida S, Sakamoto H, Kato K, Kato T, Ochiya T
Journal:Nat Commun. 2018 Oct 17;9(1):4319.
Description:to develop an optimal detection method, we use microarrays to obtain comprehensive miRNA profiles from 4046 serum samples, including 428 patients with ovarian tumors.